Drug Makers In India
Shelf life of vaccines likely to be more than 3 months, unlike drugs
Govt revises PLI scheme for bulk drugs to boost local manufacturing
PE firm PAG-led group to buy pharma firm Anjan Drug for undisclosed sum
Alembic Pharma sees domestic business growing in double digits this fiscal
Glenmark Pharma gets nod to launch favipiravir for Covid-19 patients

HCQ's emergency use revocation by US may not hit India's exports
Dr Reddy's inks pact with Gilead to manufacture, market Remdesivir in India
Gilead finds fourth partner for manufacture of Remdesivir in Zydus Cadila
With little access to doctors, drug firms go digital to stay relevant
Lupin recieves USFDA nod to market generic anthelmintic tablets

Revised Wockhardt deal boosts prospects of Dr Reddy's India business
Joint inflammation drug may be repurposed to treat Covid-19: EMBO Study
Hyderabad's Raghav Life Sciences develops Favipiravir for Covid-19 patients
Strong Q4 performance, debt reduction show Aurobindo Pharma in good health
FDA new drug approval run rate down in FY20 for most Indian pharma majors
Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business
Covid-19 lockdown: After April shock, drug sales improve in May
Coronavirus outbreak: India plans ayurvedic trials on patients soon
India's only quinine making unit set up in 1874, has been shut since 2001
Govt moves to check over-the-counter selling of coronavirus drugs